19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.

      Toxicology
      Cancer risk assessment, Hexavalent chromium [Cr(VI)], Lung cancer, Mode of action

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Inhalation of hexavalent chromium [Cr(VI)] is associated with increased lung cancer risk among workers in several industries, most notably chromate production workers exposed to high concentrations of Cr(VI) (≥100 μg/m(3)), for which clear exposure-response relationships and respiratory irritation and tissue damage have been reported. Data from this industry are used to assess lung cancer risk associated with environmental and current occupational exposures, occurring at concentrations that are significantly lower. There is considerable uncertainty in the low dose extrapolation of historical occupational epidemiology data to assess risk at current exposures because no published or well recognized mode of action (MOA) for Cr(VI)-induced lung tumors exists. We conducted a MOA analysis for Cr(VI)-induced lung cancer evaluating toxicokinetic and toxicological data in humans and rodents and mechanistic data to assess plausibility, dose-response, and temporal concordance for potential MOAs. Toxicokinetic data support that extracellular reduction of Cr(VI), which limits intracellular absorption of Cr(VI) and Cr(VI)-induced toxicity, can be overwhelmed at high exposure levels. In vivo genotoxicity and mutagenicity data are mostly negative and do not support a mutagenic MOA. Further, both chronic bioassays and the epidemiologic literature support that lung cancer occurs at exposures that cause tissue damage. Based on this MOA analysis, the overall weight of evidence supports a MOA involving deposition and accumulation of particulate chromium in the bifurcations of the lung resulting in exceedance of clearance mechanisms and cellular absorption of Cr(VI). Once inside the cell, reduction of Cr(VI) results in oxidative stress and the formation of Cr ligands. Subsequent protein and DNA damage lead to tissue irritation, inflammation, and cytotoxicity. These effects, concomitant with increased cell proliferation, result in changes to DNA sequences and/or methylation status that can lead to tumorigenesis. This MOA supports the use of non-linear approaches when extrapolating lung cancer risk occurring at high concentration occupational exposures to environmentally-relevant exposures.

          Related collections

          Author and article information

          Journal
          Toxicology
          Toxicology
          1879-3185
          0300-483X
          Nov 5 2014
          : 325
          Affiliations
          [1 ] ToxStrategies, Inc., Mission Viejo, CA 92692, United States. Electronic address: dproctor@toxstrategies.com.
          [2 ] ToxStrategies, Inc., Mission Viejo, CA 92692, United States. Electronic address: msuh@toxstrategies.com.
          [3 ] University of California, Office of the President, Oakland, CA 94612, United States. Electronic address: Sharan.Campleman@ucop.edu.
          [4 ] ToxStrategies, Inc., Katy, TX 77494, United States. Electronic address: cthompson@toxstrategies.com.
          Article
          S0300-483X(14)00168-1
          10.1016/j.tox.2014.08.009
          25174529
          ee2ed757-2478-4070-933c-07b28bcb6042
          Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
          History

          Cancer risk assessment,Hexavalent chromium [Cr(VI)],Lung cancer,Mode of action

          Comments

          Comment on this article